In General, Latest News, Press

The ProTom compact synchrotron is eagerly awaiting delivery to the ABC.  ProTom’s synchrotron will deliver proton beams to 2 gantry treatment rooms and 1 fixed beam treatment room.   The compact design allows for efficient installation in areas where other systems cannot fit.  ProTom worked closely with the ABC team to create workflow-driven and patient pleasing treatment rooms in the small building footprint available.  ProTom looks forward to being a partner with another world-class proton therapy center.

key activities for the site

Bunker walls poured up along with pre cast panel placement in preparation for treatment room 1 pour.

The latest photo on site.

The latest photo on site.

 

 

 

 

 

 

 

 

 

About Australian Bragg Centre

The Australian Bragg Centre is a $500+ million addition to the largest health and biomedical precinct in the Southern Hemisphere, Adelaide’s BioMed City.  The Australian Bragg Centre will provide a focal point for research of international calibre into the treatment of cancer, a major cause of illness in Australia.

For more information, please visit: https://www.australianbraggcentre.com

About SAHMRI

SAHMRI was the first laboratory building in Australia to be certified as a Leadership in Energy and Environment Design (LEED) Gold building. With the same high standards of design being applied to the SAHMRI 2 project, it is hoped that it will achieve a Gold rating on completion. SAHMRI 2 will be purpose built to house the world-class Proton Therapy facility, whilst the upper floors will be developed to showcase the best views and vantage points Adelaide has to offer.

For more information, please visit: https://www.sahmri.org

About ProTom International

ProTom International Holding Corporation is a medical technology company focused on proton beam therapy for patients with cancer. ProTom assembles, tests, sells and distributes the Radiance 330 Proton Therapy System®, which has FDA 510(k) clearance for commercial distribution in the United States. We are steadfast in our mission to transform cancer treatment by expanding the accessibility of proton therapy and by developing proton tomography technology. Combined with the fast return on investment, the precision of pencil beam scanning and power of integrated imaging, ProTom’s Radiance 330 proton therapy system is the choice for proton therapy technology.

Find us on Twitter, Facebook and LinkedIn